Aviso Mdico: Este contenido es informativo y educativo
By the time participants reached their maintenance dose, the worst of the gastrointestinal symptoms had typically resolved
Retatrutide is not just any peptide
ask for a Certificate of Analysis (CoA) before your first dose Semaglutide API form to verify: Ask your provider whether the compounded product uses base-form semaglutide, not unapproved salt forms (semaglutide sodium/acetate), which the FDA states have no known lawful basis for use in compounding FTC GLP-1 telehealth enforcement: The FTC finalized a December 2025 enforcement action against telehealth platform NextMed for undisclosed subscription costs and unsubstantiated GLP-1 weight loss claims
It is a triple hormone receptor agonist that targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
In the Phase 2 clinical trial (NEJM, 2023), retatrutide was administered subcutaneously at doses ranging from approximately 0.5 mg to 12 mg per week, with dose escalation under close medical supervision
